[Other] Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial

anas_hamdy Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-01 06:55
Reward20points

journalㄩAmerican Journal of Gastroenterology

AuthorsㄩPing-I Hsu; Kuan-Yang Chen; Wei-Chen Tai; Jyh-Chin Yang; Feng-Woei Tsay; Yu-Hwa Liu; Chien-Lin Chen; Chia-Long Lee; Hong-Zen Yeh; Chao-Hung Kuo; Seng-Kee Chuah; Hsi-Chang Lee; Chang-Bih Shie; Sz-Iuan Shiu; John Y. Kao; Yoshio Yamaoka; David Y. Graham; Deng-Chyang Wu;  

Published dateㄩ2023-7-

DOIㄩ10.14309/ajg.0000000000002255

PDF linkㄩhttps://www.ovid.com/10.14309/ajg.0000000000002255

Article linkㄩhttps://doi.org/10.14309/ajg.0000000000002255

Article SourceㄩOvid Technologies (Wolters Kluwer Health)﹝


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    30


Latest Reply

Daily Top Contributors

Return to the list